Two former Pfizer executives drawn into a campaign by activist investor Starboard Value to shake up the company have withdrawn their support for the plan. Pfizer's ex-chair and chief executive Ian ...

Activist investor Starboard Value has launched a broadside against Pfizer's leadership under chief executive Albert Bourla, claiming at least $20 billion in value – and possibly as much as $60 ...

Director nominees with CEO experience have long featured in Board slates put forward by activist investors. Those candidates were typically from outs ...

Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for ...

Pfizer (PFE) will end global development and commercialization of Beqvez, a gene therapy for hemophilia, Nikkei learned Thursday, after the ...

Medicare changes will cut $1 billion from 2025 revenue, with Pfizer now responsible for 20% of catastrophic drug costs. Read ...

Bullish option flow detected in Kenvue ( KVUE) Inc with 21,069 calls trading, 7x expected, and implied vol increasing almost 7 points to 32.16%. 2/28 weekly 23.5 calls and Feb-25 23.5 calls are the ...

OpenAI's board chairman on Friday said it has unanimously rejected an Elon Musk-led offer to buy the hot artificial intelligence company for $97.4 billion. "OpenAI is not for sale, and the board ...

Star disclosed on Monday that the debt proposal from Oaktree Capital Management was subject to regulatory approval and numerous other conditions. Star has warned its ability to continue as a going ...